Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

Intelicanna

OTCPK:TIGL.F
Snowflake Description

Mediocre balance sheet with weak fundamentals.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
TIGL.F
OTCPK
₪70M
Market Cap
  1. Home
  2. US
  3. Commercial Services
Company description

Intelicanna Ltd provides various management consulting services in Israel and rest of Asia, the United States, and Europe. The last earnings update was 125 days ago. More info.


Add to Portfolio Compare Print
TIGL.F Share Price and Events
7 Day Returns
0%
OTCPK:TIGL.F
-0.6%
US Professional Services
-0.1%
US Market
1 Year Returns
-
OTCPK:TIGL.F
36.1%
US Professional Services
28.2%
US Market
TIGL.F Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Intelicanna (TIGL.F) 0% 0% 0% - - -
US Professional Services -0.6% 1.3% 4.9% 36.1% 52.2% 77.6%
US Market -0.1% 2.6% 10.5% 28.2% 40.7% 53.7%
1 Year Return vs Industry and Market
  • No trading data on TIGL.F.
  • No trading data on TIGL.F.
Price Volatility
TIGL.F
Industry
5yr Volatility vs Market
Related Companies

Value

 Is Intelicanna undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.

In this section, we usually try to help investors determine whether Intelicanna is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Intelicanna has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis. You can see them here.

Show me the analysis anyway

INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Intelicanna. This is due to cash flow or dividend data being unavailable. The share price is $0.86.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Intelicanna's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Intelicanna's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
OTCPK:TIGL.F PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-06-30) in ILS ₪-9.51
TASE:INTL Share Price ** TASE (2019-10-03) in ILS ₪2.09
United States of America Professional Services Industry PE Ratio Median Figure of 37 Publicly-Listed Professional Services Companies 20.53x
United States of America Market PE Ratio Median Figure of 2,922 Publicly-Listed Companies 18.87x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Intelicanna.

OTCPK:TIGL.F PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= TASE:INTL Share Price ÷ EPS (both in ILS)

= 2.09 ÷ -9.51

-0.22x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Intelicanna is loss making, we can't compare its value to the US Professional Services industry average.
  • Intelicanna is loss making, we can't compare the value of its earnings to the United States of America market.
Price based on expected Growth
Does Intelicanna's expected growth come at a high price?
Raw Data
OTCPK:TIGL.F PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -0.22x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
United States of America Professional Services Industry PEG Ratio Median Figure of 31 Publicly-Listed Professional Services Companies 1.58x
United States of America Market PEG Ratio Median Figure of 2,040 Publicly-Listed Companies 1.56x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Intelicanna, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Intelicanna's assets?
Raw Data
OTCPK:TIGL.F PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-06-30) in ILS ₪-0.01
TASE:INTL Share Price * TASE (2019-10-03) in ILS ₪2.09
United States of America Professional Services Industry PB Ratio Median Figure of 59 Publicly-Listed Professional Services Companies 2.77x
United States of America Market PB Ratio Median Figure of 5,092 Publicly-Listed Companies 1.81x
OTCPK:TIGL.F PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= TASE:INTL Share Price ÷ Book Value per Share (both in ILS)

= 2.09 ÷ -0.01

-181.94x

* Primary Listing of Intelicanna.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Intelicanna has negative assets, we can't compare the value of its assets to the US Professional Services industry average.

Next steps:

  1. Take a look at our analysis of TIGL.F’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  2. Show me more potentially undervalued companies in the Professional Services industry
  3. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Value checks
We assess Intelicanna's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Professional Services industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Professional Services industry average (and greater than 0)? (1 check)
  5. Intelicanna has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Intelicanna expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Intelicanna has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
31.3%
Expected Professional Services industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Intelicanna expected to grow at an attractive rate?
  • Unable to compare Intelicanna's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Intelicanna's earnings growth to the United States of America market average as no estimate data is available.
  • Unable to compare Intelicanna's revenue growth to the United States of America market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
OTCPK:TIGL.F Future Growth Rates Data Sources
Data Point Source Value (per year)
United States of America Professional Services Industry Earnings Growth Rate Market Cap Weighted Average 31.3%
United States of America Professional Services Industry Revenue Growth Rate Market Cap Weighted Average 6.6%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 14.3%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.4%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
OTCPK:TIGL.F Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (6 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in ILS Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
OTCPK:TIGL.F Past Financials Data
Date (Data in ILS Millions) Revenue Cash Flow Net Income *
2019-06-30 10 0 -198
2019-03-31 18 -2 -117
2018-12-31 25 -3 -36
2018-09-30 30 -6 -44
2018-06-30 34 -8 -53
2018-03-31 37 -9 -39
2017-12-31 40 -10 -25
2017-09-30 42 -8 -17
2017-06-30 43 -9 -10
2017-03-31 46 -5 -6
2016-12-31 50 -2 -2
2016-09-30 52 -4 0

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Intelicanna is high growth as no earnings estimate data is available.
  • Unable to determine if Intelicanna is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
OTCPK:TIGL.F Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (6 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Intelicanna Company Filings, last reported 6 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:TIGL.F Past Financials Data
Date (Data in ILS Millions) EPS *
2019-06-30 -9.51
2019-03-31 -7.79
2018-12-31 -3.91
2018-09-30 -4.36
2018-06-30 -4.74
2018-03-31 -3.80
2017-12-31 -2.67
2017-09-30 -2.33
2017-06-30 -1.82
2017-03-31 -1.10
2016-12-31 -0.29
2016-09-30 -0.02

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Intelicanna will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Take a look at our analysis of TIGL.F’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  2. Intelicanna's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Commercial Services companies here
  3. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Intelicanna's filings and announcements here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Intelicanna's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Intelicanna has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Intelicanna performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Intelicanna's growth in the last year to its industry (Professional Services).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Intelicanna does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Intelicanna's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Intelicanna's 1-year growth to the US Professional Services industry average as it is not currently profitable.
Earnings and Revenue History
Intelicanna's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Intelicanna Company Filings, last reported 6 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:TIGL.F Past Revenue, Cash Flow and Net Income Data
Date (Data in ILS Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-06-30 10.40 -198.22 6.73
2019-03-31 17.65 -117.16 6.08
2018-12-31 24.91 -36.10 5.43
2018-09-30 29.62 -44.31 5.75
2018-06-30 34.34 -52.53 6.06
2018-03-31 37.39 -38.58 8.34
2017-12-31 40.44 -24.63 10.63
2017-09-30 42.33 -17.14 10.84
2017-06-30 42.68 -10.01 11.14
2017-03-31 45.91 -6.06 11.01
2016-12-31 50.20 -1.60 10.80
2016-09-30 52.49 -0.10 11.08
2016-06-30 55.89 1.41 11.19
2016-03-31 56.86 1.70 11.07
2015-12-31 55.36 1.09 10.98
2015-09-30 55.30 0.95 10.59
2015-06-30 54.88 0.93 10.38
2015-03-31 53.44 0.33 10.24
2014-12-31 53.08 0.32 10.13
2014-09-30 52.07 0.69 9.83
2014-06-30 54.09 1.38 9.97
2014-03-31 58.08 2.22 10.87
2013-12-31 62.77 2.92 11.76
2013-09-30 68.11 2.91 13.08
2013-06-30 68.64 1.72 14.28
2013-03-31 66.19 -1.30 14.64

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Intelicanna has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.
  • It is difficult to establish if Intelicanna has efficiently used its assets last year compared to the US Professional Services industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Intelicanna improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Intelicanna's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Professional Services industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Intelicanna has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Intelicanna's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Intelicanna's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Intelicanna is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Intelicanna's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Intelicanna's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Intelicanna has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Intelicanna Company Filings, last reported 6 months ago.

OTCPK:TIGL.F Past Debt and Equity Data
Date (Data in ILS Millions) Total Equity Total Debt Cash & Short Term Investments
2019-06-30 -0.37 15.06 9.82
2019-03-31 -0.37 15.06 9.82
2018-12-31 -17.95 20.78 1.38
2018-09-30 -17.95 20.78 1.38
2018-06-30 -16.91 18.97 1.04
2018-03-31 -16.91 18.97 1.04
2017-12-31 3.76 27.61 5.28
2017-09-30 3.76 27.61 5.28
2017-06-30 17.12 26.18 3.15
2017-03-31 17.12 26.18 3.15
2016-12-31 25.05 21.29 3.64
2016-09-30 26.41 19.43 2.31
2016-06-30 28.69 16.05 1.88
2016-03-31 28.79 17.27 2.16
2015-12-31 28.82 18.52 2.95
2015-09-30 24.44 25.02 7.30
2015-06-30 23.90 19.46 4.82
2015-03-31 23.68 20.43 4.83
2014-12-31 24.54 21.75 4.89
2014-09-30 25.51 20.71 4.63
2014-06-30 24.95 20.29 4.11
2014-03-31 25.29 22.12 4.13
2013-12-31 24.72 21.41 4.34
2013-09-30 24.15 22.19 4.65
2013-06-30 22.98 22.17 5.10
2013-03-31 22.24 22.92 4.91
  • Intelicanna has negative shareholder equity (liabilities exceed assets), this is a more serious situation compared with a high debt level.
  • Irrelevant to check if Intelicanna's debt level has increased considering it has negative shareholder equity.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Intelicanna has sufficient cash runway for 2.7 years based on current free cash flow.
  • Intelicanna has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of -0.8% each year.
X
Financial health checks
We assess Intelicanna's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Intelicanna has a total score of 3/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Intelicanna's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Intelicanna dividends.
If you bought $2,000 of Intelicanna shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Intelicanna's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Intelicanna's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
OTCPK:TIGL.F Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
United States of America Professional Services Industry Average Dividend Yield Market Cap Weighted Average of 18 Stocks 1%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 1962 Stocks 2.3%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.4%
United States of America Top 25% Dividend Yield 75th Percentile 3.6%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Intelicanna has not reported any payouts.
  • Unable to verify if Intelicanna's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Intelicanna's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Intelicanna has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Intelicanna's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Intelicanna afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Intelicanna has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Intelicanna's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Aaron Lichtenstein
COMPENSATION ₪0
AGE 64
TENURE AS CEO 37.9 years
CEO Bio

Mr. Aaron Lichtenstein co-founded Tefen Industrial Engineering & Management & Systems Analysis in 1982 and is its Owner and has been its Chief Executive Officer since January 1982. Mr. Lichtenstein serves as Member of the Executive Board at Tefen Industrial Engineering & Management & Systems Analysis. Mr. Lichtenstein has been leading organizational growth and establishing Tefen's reputation as the leader in the Operations Management Consulting industry. Mr. Lichtenstein's entrepreneurial spirit has been instrumental in directing the group IPO in 1994 and rapid international expansion into the U.S., Europe and Asia since 1992. Mr. Lichtenstein has created an organizational culture that creatively solves operational challenges through process excellence, leveraging solutions across virtually every type of manufacturing, service and public sector clients. Throughout his 25 years of consulting activity, he personally led dozens of global large scale operations management programs and innovatively pioneered many of the unique operations analysis and management strategies used by Tefen worldwide. Mr. Lichtenstein received a B.Sc. in Industrial Engineering from Tel-Aviv University.

CEO Compensation
  • Aaron's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Aaron's remuneration is lower than average for companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the Intelicanna management team in years:

3.8
Average Tenure
64
Average Age
  • The tenure for the Intelicanna management team is about average.
Management Team

Aaron Lichtenstein

TITLE
Co-Founder
AGE
64
TENURE
37.9 yrs

Eli Pelleg

TITLE
Corporate COO & Member of the Executive Board
AGE
61

Mally Bitzur-Parnes

TITLE
Chief Executive Officer of Tefen Israel
TENURE
2.9 yrs

Balfour Mor

TITLE
Co-Founder and Director
AGE
65
TENURE
37.9 yrs

Moran Markovitz

TITLE
Corporate CFO & Partner
TENURE
2.5 yrs

Zbigniew Brzezinski

TITLE
Managing Partner of Tefen Poland and Chief Executive Officer of Tefen Poland
TENURE
3.1 yrs

Philippe Salphati

TITLE
MD & Partner of Tefen Swiss
TENURE
2.8 yrs

Zeev Ahronson

TITLE
Head of Procurement
TENURE
3.8 yrs

Neta Lavi

TITLE
Head of Services & Operational Excellence at Tefen Israel and Partner of Tefen Israel
TENURE
3.8 yrs

Chiara Garavaglia

TITLE
Partner of Tefen Italy
COMPENSATION
₪942K
TENURE
12.2 yrs
Board of Directors

Ayal Zylberman

TITLE
Chairman of the Board
AGE
44
TENURE
4.6 yrs

Balfour Mor

TITLE
Co-Founder and Director
AGE
65
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
X
Management checks
We assess Intelicanna's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Intelicanna has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

Intelicanna Ltd provides various management consulting services in Israel and rest of Asia, the United States, and Europe. The company offers its services in the areas of corporate strategy, global strategy, marketing strategy, mergers and acquisitions, turnaround management, and innovation strategy; and sales and marketing areas, such as sales and channel management, customer relationship management, customer lifecycle, organization and capabilities, product launch, sales force efficiency, and pricing. It also provides operation and organization services in various areas comprising operational excellence, customer service, organization design, change management, and people capabilities; and services in the areas of manufacturing and quality, including quality management, lean manufacturing, six sigma, capacity planning and OEE, and facility design. In addition, the company offers services in the areas of supply chain comprising strategy and risk management, planning, procurement, distribution and logistics, and reverse logistics and green supply chain; and portfolio management, project management excellence, IT governance, risk management, and design for X methodology. Further, it provides services in the areas of corporate finance, such as financial reporting and cost controlling, financing strategy and financial control, value based management, and financial restructuring services. Additionally, the company offers Tefen AI, an artificial intelligence tool for businesses. It serves various companies in the retail, patient care, life sciences, healthcare, financial services, general manufacturing, aviation and transportation, consumer goods, telecommunications, energy and utilities, public sector, high tech, semiconductors, and legal industries. The company was formerly known as Tefen Industrial Engineering & Management & Systems Analysis and changed its name to Intelicanna Ltd. Intelicanna Ltd was founded in 1982 and is based in Beit-Dagan, Israel.

Details
Name: Intelicanna Ltd
TIGL.F
Exchange: OTCPK
Founded: 1982
₪20,239,315
33,194,975
Website: http://www.tefen.com
Address: Intelicanna Ltd
5 Menachem Boulevard Begin,
4th Floor,
Beit-Dagan,
50200,
Israel
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
TASE INTL Ordinary Shares The Tel-Aviv Stock Exchange IL ILS 03. May 1996
OTCPK TIGL.F Ordinary Shares Pink Sheets LLC US USD 03. May 1996
Number of employees
Current staff
Staff numbers
0
Intelicanna employees.
Industry
Research and Consulting Services
Commercial Services
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/01/01 00:50
End of day share price update: 2019/10/03 00:00
Last earnings filing: 2019/08/29
Last earnings reported: 2019/06/30
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.